Committee endorses referral of updated FAQs on medication‑error reporting and automated dispensing

Committee members and stakeholders reviewed proposed updates to Frequently Asked Questions on medication‑error reporting under AB 1286 and automated drug dispensing systems (ADDS) on April 16.

Staff described the proposed FAQ additions, including clarifications about camera reporting in infusion centers and guidance tied to ADDS licensing changes from AB1503 and AB447. Members complimented the reorganization and urged staff to improve plain‑English phrasing and grammar in places where drafts used passive or awkward wording.

Public commenters raised operational issues staff should address: Chazny Johnson (pharmacy technician) urged statewide QA policies that include technician roles and verification cues; NHS medication‑safety staff recommended that inspectors be briefed so local inspections interpret updated definitions consistently; lawyers and industry representatives asked for coordination with DEA guidance when ADDS intersect with federal controlled‑substance rules. Stephen Gray and others recommended referencing the DEA pharmacist manual where federal practice interpretations vary by DEA regional office. Several commenters noted a broken hyperlink to the complaint form.

On ADDS, members recommended keeping clarifying questions that specify when reporting is not required (to avoid unnecessary confusion), defining abbreviations such as ADDS/AUDS at first use, and fixing hyperlinks. The committee agreed by consensus to refer the updated FAQs to the full board for consideration and possible adoption; staff will correct grammar, repair broken links, consider adding DEA references for controlled‑substance questions, and ensure abbreviations are defined in the document.

Next steps: staff to finalize edits, repair links, and forward the revised FAQs to the full board for consideration.